Cognitive impairment induced by streptozotocin: An experimental link between diabetes and Alzheimer's disease

Streptozotocin: Uses, Mechanism of Action and Side Effects

Volumn , Issue , 2014, Pages 37-59

  Nardin, Patricia ^a   Tramontina, Ana Carolina ^b   Sesterheim, Patrícia ^c   Rodrigues, Leticia ^a   Biasibetti, Regina ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE ESTADUAL DO RIO GRANDE DO SUL   (Brazil)

^c State Foundation of Research and Production for Health (FEPPS RS)   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956709798     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (178)

1. Van Dieren S, Nöthlings U, van der Schouw YT, et al. (2011) Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus. Diabetologia 54:73-77. doi: 10.1007/s00125-010-1945-z.
2. Tun PA, Nathan DM, Perlmuter LC (1990) Cognitive and affective disorders in elderly diabetics. Clin. Geriatr. Med. 6:731-746.
3. Arvanitakis Z, Wilson RS, Bienias JL, et al. (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 61:661-666. doi: 10.1001/archneur.61.5.661.
4. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp. Gerontol. 47:858-864. doi: 10.1016/ j.exger.2012.07.014.
5. Mayer G, Nitsch R, Hoyer S (1990) Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. 532:95-100.
6. Weatherstone K, Meyer T (2012) Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Target Oncol. 7:161-168. doi: 10.1007/s11523-012-0224-y.
7. Lannert H, Hoyer S (1998) Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. 112:1199-1208.
8. Luo J, Quan J, Tsai J, et al. (1998) Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism 47:663-668.
9. Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43:1326-1333.
10. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. Acad. Sci. Bohemoslov. 50:537-546.
11. Reaven GM, Thompson LW, Nahum D, Haskins E (1990) Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13:16-21.
12. Bjørgaas M, Gimse R, Vik T, Sand T (1997) Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr. Oslo Nor. 1992 86:148-153.
13. Elms SC, Toque HA, Rojas M, et al. (2013) The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes. Diabetologia 56:654-662. doi: 10.1007/s00125-012-2789-5.
14. Sartoretto JL, Oliveira MA, Nigro D, et al. (2007) Constrictor responses to noradrenaline, hemodynamic profile, and superoxide levels measured by hydroethidine oxidation in diabetic rats. Biol. Pharm. Bull. 30:1938-1942.
15. Gispen WH, Biessels GJ (2000) Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23:542-549.
16. Chabot C, Massicotte G, Milot M, et al. (1997) Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res. 768:249-256.
17. Salkovic-Petrisic M, Tribl F, Schmidt M, et al. (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J. Neurochem. 96:1005-1015. doi: 10.1111/j.1471-4159.2005.03637.x.
18. Coleman ES, Dennis JC, Braden TD, et al. (2010) Insulin treatment prevents diabetes-induced alterations in astrocyte glutamate uptake and GFAP content in rats at 4 and 8 weeks of diabetes duration. Brain Res. 1306:131-141. doi: 10.1016/j.brainres. 2009.10.005.
19. Revsin Y, Rekers NV, Louwe MC, et al. (2009) Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacol Off. Publ. Am. Coll. Neuropsychopharmacol. 34:747-758. doi: 10.1038/npp.2008.136.
20. Gandhi GK, Ball KK, Cruz NF, Dienel GA (2010) Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro 2:e00030. doi: 10.1042/ AN20090048.
21. Zhang T, Pan B-S, Zhao B, et al. (2009) Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and betaamyloid generation in rat brains. Neuroscience 161:1045-1056. doi: 10.1016/j.neuroscience.2009.04.032.
22. Van der Heide LP, Ramakers GMJ, Smidt MP (2006) Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol. 79:205-221. doi: 10.1016/j.pneurobio.2006.06.003
23. Pang ZP, Han W (2012) Regulation of synaptic functions in central nervous system by endocrine hormones and the maintenance of energy homoeostasis. Biosci. Rep. 32:423-432. doi: 10.1042/BSR20120026.
24. Huang X, Wang F, Chen W, et al. (2012) Possible link between the cognitive dysfunction associated with diabetes mellitus and the neurotoxicity of methylglyoxal. Brain Res. 1469:82-91. doi: 10.1016/j.brainres.2012.06.011.
25. Jiang L-Y, Tang S-S, Wang X-Y, et al. (2012) PPARγ agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. CNS Neurosci. Ther. 18:659-666. doi: 10.1111/j.1755-5949.2012.00341.x.
26. Daroux M, Prévost G, Maillard-Lefebvre H, et al. (2010) Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab. 36:1-10. doi: 10.1016/j.diabet.2009.06.005.
27. Biessels GJ, van der Heide LP, Kamal A, et al. (2002) Ageing and diabetes: implications for brain function. Eur. J. Pharmacol. 441:1-14.
28. Revsin Y, Saravia F, Roig P, et al. (2005) Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res. 1038:22-31. doi: 10.1016/j.brainres.2004.12.032.
29. Wang DD, Bordey A (2008) The astrocyte odyssey. Prog. Neurobiol. 86:342-367. doi: 10.1016/j.pneurobio.2008.09.015.
30. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol. (Berl) 119:7-35. doi: 10.1007/s00401-009-0619-8.
31. Liberto CM, Albrecht PJ, Herx LM, et al. (2004) Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89:1092-1100. doi: 10.1111/j.1471-4159. 2004.02420.x.
32. Saravia FE, Revsin Y, Gonzalez Deniselle MC, et al. (2002) Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res. 957:345-353.
33. Lu M, Xu L, Li B, et al. (2010) Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway. J. Nutr. Sci. Vitaminol. (Tokyo) 56:87-97.
34. Baydas G, Nedzvetskii VS, Tuzcu M, et al. (2003) Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462:67-71.
35. Baydas G, Reiter RJ, Yasar A, et al. (2003) Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol. Med. 35:797-804.
36. Feit-Leichman RA, Kinouchi R, Takeda M, et al. (2005) Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest. Ophthalmol Vis. Sci. 46:4281-4287. doi: 10.1167/iovs.04-1361.
37. Coleman E, Judd R, Hoe L, et al. (2004) Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48:166-178. doi: 10.1002/glia.20068.
38. De Senna PN, Ilha J, Baptista PPA, et al. (2011) Effects of physical exercise on spatial memory and astroglial alterations in the hippocampus of diabetic rats. Metab. Brain Dis. 26:269-279. doi: 10.1007/s11011-011-9262-x.
39. Dasuri K, Zhang L, Keller JN (2013) Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol. Med. 62:170-185. doi: 10.1016/j.freeradbiomed.2012.09.016.
40. Allen DA, Yaqoob MM, Harwood SM (2005) Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J. Nutr. Biochem. 16:705-713. doi: 10.1016/j.jnutbio.2005.06.007.
41. Matkovics B, Kotorman M, Varga IS, et al. (1997) Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol. Hung. 85:29-38.
42. Mastrocola R, Restivo F, Vercellinatto I, et al. (2005) Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J. Endocrinol. 187:37-44. doi: 10.1677/joe.1.06269.
43. Kabay SC, Ozden H, Guven G, et al. (2009) Protective effects of vitamin E on central nervous system in streptozotocin-induced diabetic rats. Clin. Investig. Med. Médecine Clin. Exp. 32:E314-321.
44. Kade IJ, Rocha JBT (2013) Gallic acid modulates cerebral oxidative stress conditions and activities of enzyme-dependent signaling systems in streptozotocin-treated rats. Neurochem. Res. 38:761-771. doi: 10.1007/s11064-013-0975-6.
45. Moghaddam HK, Baluchnejadmojarad T, Roghani M, et al. (2013) Berberine Ameliorate Oxidative Stress and Astrogliosis in the Hippocampus of STZ-Induced Diabetic Rats. Mol. Neurobiol. doi: 10.1007/s12035-013-8559-7.
46. Guglielmotto M, Aragno M, Tamagno E, et al. (2012) AGEs/RAGE complex upregulates BACE1 via NF-kB pathway activation. Neurobiol. Aging 33:196.e13-27. doi: 10.1016/j.neurobiolaging.2010.05.026.
47. Liu LP, Hong H, Liao JM, et al. (2009) Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice. Synap New York N 63:636-642. doi: 10.1002/syn.20644.
48. Zong H, Ward M, Madden A, et al. (2010) Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 53:2656-2666. doi: 10.1007/ s00125-010-1900-z.
49. Younessi P, Yoonessi A (2011) Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J. Med. Sci. 36:154-166.
50. Havrankova J, Roth J, Brownstein M (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272:827-829.
51. Pacold ST, Blackard WG (1979) Central nervous system insulin receptors in normal and diabetic rats. Endocrinology 105:1452-1457.
52. Devaskar S, McMenamy K, Holtzclaw L, Sadiq F (1990) Long-term maternal-fetal exposure to high-low insulin concentrations alter liver but not brain insulin receptors. Am. J. Obstet. Gynecol. 163:1350-1356.
53. Pezzino V, Costantino A, Russo P, et al. (1996) Insulin receptor content in tissues of normal and diabetic rats measured by radioimmunoassay. J. Endocrinol. Invest. 19: 593-597.
54. Dou J-T, Chen M, Dufour F, et al. (2005) Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem. Cold Spring Harb. N 12:646-655. doi: 10.1101/lm.88005.
55. Kumar PT, Antony S, Nandhu MS, et al. (2011) Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats. J. Nutr. Biochem. 22:418-425. doi: 10.1016/j.jnutbio.2010.03.010.
56. Peeyush KT, Savitha B, Sherin A, et al. (2010) Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with Vitamin D3 supplementation. Pharmacol. Biochem. Behav. 95:216-222. doi: 10.1016/j.pbb.2010.01.008.
57. Ward MM, Jobling AI, Kalloniatis M, Fletcher EL (2005) Glutamate uptake in retinal glial cells during diabetes. Diabetologia 48:351-360. doi: 10.1007/s00125-004-1639-5.
58. Mehta A, Prabhakar M, Kumar P, et al. (2013) Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 698:6-18. doi: 10.1016/j.ejphar.2012.10.032.
59. Matute C, Domercq M, Sánchez-Gómez M-V (2006) Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 53:212-224. doi: 10.1002/glia.20275.
60. Joseph A, Antony S, Paulose CS (2008) Increased glutamate receptor gene expression in the cerebral cortex of insulin induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience 156:298-304. doi: 10.1016/j.neuroscience. 2008.07.022.
61. Jayanarayanan S, Smijin S, Peeyush KT, et al. (2013) NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin. Chem. Biol. Interact. 201:39-48. doi: 10.1016/j.cbi. 2012.11.024.
62. Wasilewska M, Adamiec R (2012) Cerebral regulation of insulin secretion and the development of insulin resistance in type 2 diabetes. Adv. Clin. Exp. Med. Off. Organ Wroclaw. Med. Univ. 21:695-703.
63. Bhardwaj SK, Sandhu SK, Sharma P, Kaur G (1999) Impact of diabetes on CNS: role of signal transduction cascade. Brain Res. Bull. 49:155-162.
64. Sherin A, Anu J, Peeyush KT, et al. (2012) Cholinergic and GABAergic receptor functional deficit in the hippocampus of insulin-induced hypoglycemic and streptozotocin-induced diabetic rats. Neuroscience 202:69-76. doi: 10.1016/ j.neuroscience.2011.11.058.
65. Antony S, Kumar TP, Kuruvilla KP, et al. (2010) Decreased GABA receptor binding in the cerebral cortex of insulin induced hypoglycemic and streptozotocin induced diabetic rats. Neurochem. Res. 35:1516-1521. doi: 10.1007/s11064-010-0210-7.
66. Robinson R, Krishnakumar A, Paulose CS (2009) Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats. Cell Mol. Neurobiol. 29:365-372. doi: 10.1007/s10571-008-9328-4.
67. Greene DA, Lattimer SA, Sima AA (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316:599-606. doi: 10.1056/NEJM198703053161007.
68. Leong SF, Leung TK (1991) Diabetes induced by streptozotocin causes reduced Na-K ATPase in the brain. Neurochem. Res. 16:1161-1165.
69. Oner P, Oztaş. B, Koçak H (1997) Brain cortex Na(+)-K+ ATPase activities in streptozotocin-diabetic and pentylenetetrazol-epileptic rats. Pharmacol. Res. Off. J. Ital. Pharmacol. Soc. 36:69-72. doi: 10.1006/phrs.1997.0208.
70. Franzon R, Chiarani F, Mendes RH, et al. (2005) Dietary soy prevents brain Na+, K(+)-ATPase reduction in streptozotocin diabetic rats. Diabetes Res. Clin. Pract. 69: 107-112. doi: 10.1016/j.diabres.2004.11.010.
71. Kamboj SS, Chopra K, Sandhir R (2009) Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation. Neuroscience 162:349-358. doi: 10.1016/ j.neuroscience.2009.05.002.
72. Faraci FM, Heistad DD (1998) Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol. Rev. 78:53-97.
73. Minami K, Miki T, Kadowaki T, Seino S (2004) Roles of ATP-sensitive K+ channels as metabolic sensors: studies of Kir6.x null mice. Diabetes 53 Suppl 3:S176-180.
74. Heng L-J, Yang R-H, Jia D (2011) Diabetes impairs learning performance through affecting membrane excitability of hippocampal pyramidal neurons. Behav. Brain Res. 224:250-258. doi: 10.1016/j.bbr.2011.05.043.
75. Gonçalves C-A, Leite MC, Nardin P (2008) Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin. Biochem. 41: 755-763. doi: 10.1016/j.clinbiochem.2008.04.003.
76. Donato R (2003) Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60:540-551. doi: 10.1002/jemt.10296.
77. Donato R, Sorci G, Riuzzi F, et al. (2009) S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 1793:1008-1022. doi: 10.1016/j.bbamcr.2008.11.009.
78. Ostendorp T, Leclerc E, Galichet A, et al. (2007) Structural and functional insights into RAGE activation by multimeric S100B. EMBO J. 26:3868-3878. doi: 10.1038/sj.emboj.7601805.
79. Ponath G, Schettler C, Kaestner F, et al. (2007) Autocrine S100B effects on astrocytes are mediated via RAGE. J. Neuroimmunol. 184:214-222. doi: 10.1016/ j.jneuroim.2006.12.011.
80. Van Eldik LJ, Wainwright MS (2003) The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor. Neurol. Neurosci. 21:97-108.
81. Michetti F, Corvino V, Geloso MC, et al. (2012) The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J. Neurochem. 120:644-659. doi: 10.1111/j.1471-4159.2011.07612.x.
82. Berger RP, Beers SR, Richichi R, et al. (2007) Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma 24:1793-1801. doi: 10.1089/neu.2007.0316.
83. Tanaka Y, Marumo T, Omura T, Yoshida S (2008) Relationship between cerebrospinal and peripheral S100B levels after focal cerebral ischemia in rats. Neurosci. Lett. 436:40-43. doi: 10.1016/j.neulet.2008.02.056.
84. Schroeter ML, Sacher J, Steiner J, et al. (2013) Serum S100B represents a new biomarker for mood disorders. Curr. Drug Targets 14:1237-1248.
85. Steiner J, Bogerts B, Schroeter ML, Bernstein H-G (2011) S100B protein in neurodegenerative disorders. Clin. Chem. Lab. Med. CCLM FESCC 49:409-424. doi: 10.1515/CCLM.2011.083.
86. Chaves ML, Camozzato AL, Ferreira ED, et al. (2010) Serum levels of S100B and NSE proteins in Alzheimer's disease patients. J. Neuroinflammation 7:6. doi: 10.1186/ 1742-2094-7-6.
87. Gonçalves CA, Leite MC, Guerra MC (2010) Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue. Cardiovasc. Psychiatry Neurol. 2010:790431. doi: 10.1155/2010/790431.
88. Hovsepyan MR, Haas MJ, Boyajyan AS, et al. (2004) Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus. Neurosci. Lett. 369: 224-227. doi: 10.1016/j.neulet.2004.07.071.
89. Penfold SA, Coughlan MT, Patel SK, et al. (2010) Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int. 78:287-295. doi: 10.1038/ki.2010.134.
90. Shanmugam N, Todorov IT, Nair I, et al. (2006) Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice. Diabetologia 49:100-107. doi: 10.1007/s00125-005-0065-7.
91. Reddy MA, Li S-L, Sahar S, et al. (2006) Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J. Biol. Chem. 281:13685-13693. doi: 10.1074/jbc.M511425200.
92. Zimmer DB, Chessher J, Wilson GL, Zimmer WE (1997) S100A1 and S100B expression and target proteins in type I diabetes. Endocrinology 138:5176-5183.
93. Nardin P, Tramontina F, Leite MC, et al. (2007) S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem. Int. 50:774-782. doi: 10.1016/j.neuint.2007.01.013.
94. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N. Engl. J. Med. 362:329-344. doi: 10.1056/NEJMra0909142.
95. Candore G, Bulati M, Caruso C, et al. (2010) Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. 13:301-313. doi: 10.1089/rej.2009.0993.
96. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298:789-791. doi: 10.1126/science.1074069.
97. Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34:385-397.
98. Correia SC, Santos RX, Perry G, et al. (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Res. Rev. 10:264-273. doi: 10.1016/ j.arr.2011.01.001.
99. De la Monte SM, Wands JR (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J. Diabetes Sci. Technol. 2:1101-1113.
100. Simpson IA, Chundu KR, Davies-Hill T, et al. (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35:546-551. doi: 10.1002/ana.410350507.
101. Gibson GE, Sheu KF, Blass JP, et al. (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch. Neurol. 45:836-840.
102. Mastrogiacoma F, Bettendorff L, Grisar T, Kish SJ (1996) Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. Ann. Neurol. 39:585-591. doi: 10.1002/ana.410390507.
103. Mattson MP, Gary DS, Chan SL, Duan W (2001) Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease. Biochem. Soc. Symp. 151-162.
104. Frölich L, Blum-Degen D, Bernstein HG, et al. (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural. Transm. Vienna Austria 1996 105:423-438.
105. Lester-Coll N, Rivera EJ, Soscia SJ, et al. (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. JAD 9:13-33.
106. Rivera EJ, Goldin A, Fulmer N, et al. (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J. Alzheimers Dis. JAD 8:247-268.
107. Watson GS, Craft S (2004) Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur. J. Pharmacol. 490:97-113. doi: 10.1016/j.ejphar.2004.02.048.
108. Sharma M, Gupta YK (2001) Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 68:1021-1029.
109. Mayer, G., Nitsch, R., Hoyer, S. (1989) Impairments in passive avoidance learning after cerebral inhibition of cerebral glucose metabolism. J. Neural. Transm. 1 Park Dis. Dement. Sect. 103-104.
110. Hellweg R, Nitsch R, Hock C, et al. (1992) Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. J. Neurosci. Res. 31:479-486. doi: 10.1002/jnr.490310310.
111. Rodrigues L, Dutra MF, Ilha J, et al. (2010) Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin. J. Neural. Transm. Vienna Austria 1996 117:1295-1305. doi: 10.1007/s00702-010-0501-9.
112. Sharma M, Gupta YK (2002) Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 71:2489-2498.
113. Tramontina AC, Wartchow KM, Rodrigues L, et al. (2011) The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats. J. Neural. Transm. Vienna Austria 1996 118:1641-1649. doi: 10.1007/s00702-011-0680-z.
114. Duelli R, Schröck H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci. 12:737-743.
115. Pathan AR, Viswanad B, Sonkusare SK, Ramarao P (2006) Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats. Life Sci. 79:2209-2216. doi: 10.1016/j.lfs.2006.07.018.
116. Plaschke K, Hoyer S (1993) Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci. 11:477-483.
117. Nitsch R, Hoyer S (1991) Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci. Lett. 128:199-202.
118. Gerozissis K (2008) Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur. J. Pharmacol. 585:38-49. doi: 10.1016/ j.ejphar.2008.01.050.
119. Baki L, Neve RL, Shao Z, et al. (2008) Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signaling. J. Neurosci. Off. J. Soc. Neurosci. 28:483-490. doi: 10.1523/ JNEUROSCI.4067-07.2008.
120. Gasparini L, Netzer WJ, Greengard P, Xu H (2002) Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23:288-293.
121. Steen E, Terry BM, Rivera EJ, et al. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J. Alzheimers Dis. JAD 7:63-80.
122. Grünblatt E, Salkovic-Petrisic M, Osmanovic J, et al. (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J. Neurochem. 101:757-770. doi: 10.1111/j.1471-4159.2006.04368.x.
123. Deng Y, Li B, Liu Y, et al. (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. Am. J. Pathol. 175:2089-2098. doi: 10.2353/ajpath.2009.090157.
124. De la Monte SM, Tong M, Lester-Coll N, et al. (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease. J Alzheimers Dis. JAD 10:89-109.
125. Ferrer I, Gomez-Isla T, Puig B, et al. (2005) Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr. Alzheimer Res. 2:3-18.
126. Xiong H, Zheng C, Wang J, et al. (2013) The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice. J. Alzheimers Dis. JAD 37:623-635. doi: 10.3233/JAD-130584.
127. Zhou S, Yu G, Chi L, et al. (2013) Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats. Neurotoxicology 38:136-145. doi: 10.1016/j.neuro.2013.07.007.
128. Ke YD, Delerue F, Gladbach A, et al. (2009) Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease. PloS One 4:e7917. doi: 10.1371/journal.pone.0007917.
129. Plaschke K, Kopitz J, Siegelin M, et al. (2010) Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J. Alzheimers Dis. JAD 19:691-704. doi: 10.3233/JAD-2010-1270.
130. Salkovic-Petrisic M, Knezovic A, Hoyer S, Riederer P (2013) What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J. Neural. Transm. Vienna Austria 1996 120:233-252. doi: 10.1007/s00702-012-0877-9.
131. Ishrat T, Khan MB, Hoda MN, et al. (2006) Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav. Brain Res. 171:9-16. doi: 10.1016/j.bbr.2006.03.009.
132. Prickaerts J, Fahrig T, Blokland A (1999) Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav. Brain Res. 102:73-88.
133. Biasibetti R, Tramontina AC, Costa AP, et al. (2013) Green tea (-)epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav. Brain Res. 236:186-193. doi: 10.1016/j.bbr.2012.08.039.
134. Sodhi RK, Singh N (2013) Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PloS One 8:e70487. doi: 10.1371/journal.pone.0070487.
135. Paula-Lima AC, Brito-Moreira J, Ferreira ST (2013) Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease. J. Neurochem. 126:191-202. doi: 10.1111/jnc.12304
136. Robinson SR (2001) Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease. J. Neurosci. Res. 66:972-980.
137. Verkhratsky A, Olabarria M, Noristani HN, et al. (2010) Astrocytes in Alzheimer's disease. Neurother. J. Am. Soc. Exp. Neurother. 7:399-412. doi: 10.1016/ j.nurt.2010.05.017.
138. Van Eldik LJ, Griffin WS (1994) S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta 1223:398-403.
139. Nagele RG, Wegiel J, Venkataraman V, et al. (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol. Aging 25:663-674. doi: 10.1016/j.neurobiolaging.2004.01.007.
140. Sheng JG, Mrak RE, Bales KR, et al. (2000) Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J. Neurochem. 74:295-301.
141. Mori T, Koyama N, Arendash GW, et al. (2010) Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia 58:300-314. doi: 10.1002/glia.20924.
142. Rothermundt M, Peters M, Prehn JHM, Arolt V (2003) S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60:614-632. doi: 10.1002/jemt.10303.
143. Hosseinzadeh S, Zahmatkesh M, Zarrindast M-R, et al. (2013) Elevated CSF and plasma microparticles in a rat model of streptozotocin-induced cognitive impairment. Behav. Brain Res. 256:503-511. doi: 10.1016/j.bbr.2013.09.019.
144. Vicente E, Degerone D, Bohn L, et al. (2009) Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat. Brain Res. 1251:204-212. doi: 10.1016/ j.brainres.2008.11.032.
145. Costa AP, Tramontina AC, Biasibetti R, et al. (2012) Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia. Behav. Brain Res. 226:420-427. doi: 10.1016/j.bbr.2011.09.035.
146. Weinstock M, Shoham S (2004) Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J. Neural. Transm. Vienna Austria 1996 111:347-366. doi: 10.1007/s00702-003-0058-y.
147. Chen Y, Liang Z, Blanchard J, et al. (2013) A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Mol. Neurobiol. 47:711-725. doi: 10.1007/s12035-012-8375-5.
148. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U S A 91:10625-10629.
149. Guzmán M, Blázquez C (2001) Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol. Metab. TEM 12:169-173.
150. Pfrieger FW, Ungerer N (2011) Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50:357-371. doi: 10.1016/j.plipres.2011.06.002.
151. Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol. Chem. 384: 505-516. doi: 10.1515/BC.2003.059.
152. Cooper AJL (2012) The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis. Neurochem. Res. 37:2439-2455. doi: 10.1007/s11064-012-0803-4.
153. Schousboe A, Bak LK, Waagepetersen HS (2013) Astrocytic Control of Biosynthesis and Turnover of the Neurotransmitters Glutamate and GABA. Front Endocrinol. 4:102. doi: 10.3389/fendo.2013.00102.
154. Townsend M, Mehta T, Selkoe DJ (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 282: 33305-33312. doi: 10.1074/jbc.M610390200.
155. Grodstein F, Chen J, Wilson RS, et al. (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24:1060-1065.
156. Park SA (2011) A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models. J. Clin. Neurol. Seoul Korea 7:10-18. doi: 10.3988/jcn.2011.7.1.10.
157. Reitz C (2012) Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int. J. Alzheimers Dis. 2012:369808. doi: 10.1155/2012/369808.
158. Chen Z, Zhong C (2013) Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog. Neurobiol. 108:21-43. doi: 10.1016/j.pneurobio.2013.06.004.
159. Mosconi L, De Santi S, Li Y, et al. (2006) Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur. J. Nucl. Med. Mol. Imaging 33:210-221. doi: 10.1007/s00259-005-1956-z.
160. Cunnane S, Nugent S, Roy M, et al. (2011) Brain fuel metabolism, aging, and Alzheimer's disease. Nutr. Burbank Los Angeles Cty Calif. 27:3-20. doi: 10.1016/ j.nut.2010.07.021.
161. Jakobsen J, Nedergaard M, Aarslew-Jensen M, Diemer NH (1990) Regional brain glucose metabolism and blood flow in streptozocin-induced diabetic rats. Diabetes 39:437-440.
162. Heo J-H, Lee S-R, Lee S-T, et al. (2011) Spatial distribution of glucose hypometabolism induced by intracerebroventricular streptozotocin in monkeys. J. Alzheimers Dis. JAD 25:517-523. doi: 10.3233/JAD-2011-102079.
163. Cardoso S, Santos RX, Correia SC, et al. (2012) Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance. Neurobiol. Dis. 49C:1-12. doi: 10.1016/j.nbd.2012.08.008.
164. Pekny M, Pekna M (2004) Astrocyte intermediate filaments in CNS pathologies and regeneration. J. Pathol. 204:428-437. doi: 10.1002/path.1645.
165. Saxena G, Patro IK, Nath C (2011) ICV STZ induced impairment in memory and neuronal mitochondrial function: A protective role of nicotinic receptor. Behav. Brain Res. 224:50-57. doi: 10.1016/j.bbr.2011.04.039.
166. Zhou Y, Qu Z, Zeng Y, et al. (2012) Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp. Toxicol. Pathol. Off. J. Ges. Für Toxikol. Pathol. 64:673-680. doi: 10.1016/j.etp.2010.12.011.
167. Thorens B (1996) Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am. J. Physiol. 270:G541-553.
168. Unger RH (1991) Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. Science 251:1200-1205.
169. Brant AM, Jess TJ, Milligan G, et al. (1993) Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem. Biophys. Res. Commun. 192:1297-1302. doi: 10.1006/bbrc.1993.1557.
170. Navarro M, Rodriquez de Fonseca F, Alvarez E, et al. (1996) Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J. Neurochem. 67:1982-1991.
171. Rodriguez EM, Blázquez JL, Pastor FE, et al. (2005) Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int. Rev. Cytol. 247:89-164. doi: 10.1016/S0074-7696(05)47003-5.
172. Leloup C, Arluison M, Lepetit N, et al. (1994) Glucose transporter 2 (GLUT 2): expression in specific brain nuclei. Brain Res. 638:221-226.
173. Baydas G, Sonkaya E, Tuzcu M, et al. (2005) Novel role for gabapentin in neuroprotection of central nervous system in streptozotocine-induced diabetic rats. Acta Pharmacol. Sin. 26:417-422. doi: 10.1111/j.1745-7254.2005.00072.x.
174. Dennis JC, Coleman ES, Swyers SE, et al. (2005) Changes in mitotic rate and GFAP expression in the primary olfactory axis of streptozotocin-induced diabetic rats. J. Neurocytol. 34:3-10. doi: 10.1007/s11068-005-5044-x.
175. Lebed YV, Orlovsky MA, Nikonenko AG, et al. (2008) Early reaction of astroglial cells in rat hippocampus to streptozotocin-induced diabetes. Neurosci. Lett. 444:181-185. doi: 10.1016/j.neulet.2008.07.094.
176. Collino M, Aragno M, Castiglia S, et al. (2009) Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Diabetes 58:235-242. doi: 10.2337/db08-0691.
177. Rodrigues L, Biasibetti R, Swarowsky A, et al. (2009) Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine. J. Alzheimers Dis. JAD 17:193-202. doi: 10.3233/JAD-2009-1034.
178. 2 production in mice synaptosomes. J. Alzheimers Dis. JAD 30: 889-898. doi: 10.3233/JAD-2012-112066.